Late additionBuy-out

BC Partners acquires InfoRLife

CDMO for IV infusion bags · Switzerland

SourcingClub was not involved in this transaction.

BC Partners acquires a co-control stake in InfoRLife together with the founding families of ACS Dobfar. InfoRLife develops and produces ready-to-use IV infusion bags as a dossier developer and CDMO.

In context

Latham & Watkins is named as adviser on 8 deals on the Deal-Radar. The Deal-Radar lists 5 deals in Healthcare for July 2026, this is the 5th.

Deal-Radar editorial team · responsible:

late addition, source dated 28 Jul 2026: bcpartners.com

Who was involved.

Target
InfoRLife
Seller
Gründer und CEO, Gründerfamilien von ACS Dobfar
Type
Buy-out
Country
Switzerland
Source dated
28/07/2026
Sell-side
Alira Health,LCAaccording to the source
Buy-side
Latham & Watkins,Studio Legale Tributario Facchini Rossi Michelutti,PwC,Bär & Karrer,Jefferies,Rothschildaccording to the source

Deal-Radar no. 47-176 · added in Week 47/2026, first reported on 28/07/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them. The context is based only on deals recorded in the Deal-Radar and is not complete.

Valuation in this industry.

5.9 to 10.0times EBITDA

  • 5.9x to 7.6xRevenue under €5m
  • 7.0x to 9.0x€5m to €50m
  • 8.2x to 10.0xover €50m

Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.

July 2026 on the Deal-Radar.

8 of 28 deals were of the type Buy-out.

  1. Buy-out8
  2. Secondary5
  3. Minority stake4
  4. Strategic4
  5. Add-on3
  6. Carve-out2
  7. Succession1
  8. Funding round1

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 21 November 2026.